Biomarkers in Pediatric Lung Diseases Including Cystic Fibrosis

  • Parisi G
  • Papale M
  • Tardino L
  • et al.
6Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

© 2019 Bentham Science Publishers. In recent decades, scientific studies of chemical processes involving metabolites have been steadily increasing, indicating that we are well into the metabolomics era. This has resulted in numerous studies that explore the field of biomarkers. One of the medical areas most concerned with these innovations is certainly that of childhood respiratory disorders, including asthma and cystic fibrosis. This current study is a review of the literature about biomarkers used or studied in the field of pediatric pulmonology, including asthma and cystic fibrosis.

Cite

CITATION STYLE

APA

Parisi, G. F., Papale, M., Tardino, L., Nenna, R., Midulla, F., & Leonardi, S. (2020). Biomarkers in Pediatric Lung Diseases Including Cystic Fibrosis. Current Respiratory Medicine Reviews, 15(3), 163–173. https://doi.org/10.2174/1573398x15666190521112824

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free